Citius Pharmaceuticals (CTXR) Payables (2011 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Payables came in at $9.5 million in Q1 2026, up 0.91% YoY from $9.4 million in Q1 2025, and down 21.36% on a QoQ basis from $12.0 million in Q4 2025.
Citius Pharmaceuticals (CTXR) Payables (2011 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 16 years of Payables data on file, last reported at $9.5 million in Q1 2026.
- Quarterly Payables rose 0.91% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (up 0.91% YoY) and the FY2025 annual result came in at $14.7 million, up 198.22% from the prior year.
- Payables declined to $9.5 million in Q1 2026, from $12.0 million in the prior quarter.
- In the past five years, Payables ranged from a high of $14.7 million in Q3 2025 to a low of $1.2 million in Q3 2022.
- A 5-year average of $5.3 million and a median of $2.9 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables plunged 45.99% — and 2025, when it surged 566.98%.
- Tracing CTXR's Payables over 5 years: stood at $1.5 million in 2022, then surged by 72.17% to $2.6 million in 2023, then soared by 178.18% to $7.4 million in 2024, then surged by 63.24% to $12.0 million in 2025, then decreased by 21.36% to $9.5 million in 2026.
- The last three Payables figures came in at $9.5 million (Q1 2026), $12.0 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 35.57 Mn |
| 10 | Citius Pharmaceuticals | 15.88 Mn | 15.88 Mn | 1.00 Mn | 8.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.45 Mn |
| Dec 31, 2025 | 12.02 Mn |
| Sep 30, 2025 | 14.69 Mn |
| Jun 30, 2025 | 11.09 Mn |
| Mar 31, 2025 | 9.37 Mn |
| Dec 31, 2024 | 7.36 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 2.65 Mn |
| Sep 30, 2023 | 2.93 Mn |
| Jun 30, 2023 | 3.08 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 1.54 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 1.35 Mn |